Nephrolithiasis (NL) is common, and symptomatic stone episodes cause significant pain, suffering, and economic cost. Much effort has been expended to define metabolic abnormalities that increase urinary supersaturation (SS), and thereby favor stone growth. However, currently available treatments that reduce urinary SS are not completely effective. Therefore, new understanding of additional pathogenic factors is needed to suggest new preventative strategies. Recent studies highlight the importance of NL precursor lesions, including Randall's plaques and plugs within distal tubular lumens. Qur preliminary data suggest that a subset of so-called """"""""idiopathic"""""""" CaOx stones may also begin from tubular plugs. Clinical kidney stone research has lagged because stone passage is the final result of many earlier events, and this series of events likely differs between apparently similar patients. Contributors to urinary SS (e.g. calcium excretion) are clearly important, but other factors such as cellular responses to SS and crystals or protein crystallization inhibitors also contribute to stone formation. We hypothesize that clinical studies to investigate stone pathogenesis have likely been confounded by the (unknown) variety of underlying renal pathologies. Therefore, we plan to carefully phenotype renal stone precursor lesions by direct endoscopic visualization. These carefully pheontyped patients will be used to develop imaging algorithms to noninvasively characterize stone composition and precursor lesions, to define the gene expression of papillary tissue of patients with and without plaque, and determine the urine and stone microbiome of diverse patient types.
Specific Aims are:
Aim 1 Accurately map kidney stone location and precursor lesions after percutaneous nephrolithotomy in defined groups of patients with idiopathic CaQx stones (n=220), enteric hyperoxaluria (n=15), primary hyperoxaluria (n=5);uric acid stones (n=20);CaP stones (n=30), cystine stones (n=5), and controls without stones (n=30) Aim 2: Define dual energy CT algorithms to predict stone fragility Aim 3: Determine the gene expression profile of papillary tip biopsies with maximal and minimal plaque and plugs.
Aim 4 : Characterize the microbiome of urine and kidney stones of patients with diverse types of stones.
These aims build upon the preliminary data assembled by our multidisciplinary group over the last 4 years.

Public Health Relevance

Our studies and others have highlighted the diverse array of renal pathologies that can be present in similar types of stone patients. New knowledge regarding the precise pathogenic pathways that can lead to stones is required in order to identify susceptible patients and to develop alternative strategies to prevent stones. These advances will eliminate the personal burden of stone disease including pain, infection, lost productivity, and costs associated with treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54DK100227-01
Application #
8626065
Study Section
Special Emphasis Panel (ZDK1-GRB-9 (M2))
Project Start
Project End
Budget Start
2013-09-29
Budget End
2014-06-30
Support Year
1
Fiscal Year
2013
Total Cost
$185,141
Indirect Cost
$68,311
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Rule, Andrew D; Kremers, Walter K (2016) What Is the Correct Approach for Comparing GFR by Different Methods across Levels of GFR? Clin J Am Soc Nephrol 11:1518-21
Leng, Shuai; Huang, Alice; Cardona, Juan Montoya et al. (2016) Dual-Energy CT for Quantification of Urinary Stone Composition in Mixed Stones: A Phantom Study. AJR Am J Roentgenol 207:321-9
Perinpam, Majuran; Ware, Erin B; Smith, Jennifer A et al. (2016) Key influence of sex on urine volume and osmolality. Biol Sex Differ 7:12
Jaeger, Christopher D; Rule, Andrew D; Mehta, Ramila A et al. (2016) Endoscopic and Pathologic Characterization of Papillary Architecture in Struvite Stone Formers. Urology 90:39-44
Landry, Greg M; Hirata, Taku; Anderson, Jacob B et al. (2016) Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol 310:F152-9
Haley, William E; Enders, Felicity T; Vaughan, Lisa E et al. (2016) Kidney Function After the First Kidney Stone Event. Mayo Clin Proc 91:1744-1752
Giesen, Callen; Lieske, John C (2016) The Influence of Processing and Storage Conditions on Renal Protein Biomarkers. Clin J Am Soc Nephrol :
Ferrero, Andrea; Montoya, Juan C; Vaughan, Lisa E et al. (2016) Quantitative Prediction of Stone Fragility From Routine Dual Energy CT: Ex vivo proof of Feasibility. Acad Radiol 23:1545-1552
Lieske, John C; Turner, Stephen T; Edeh, Samuel N et al. (2016) Heritability of dietary traits that contribute to nephrolithiasis in a cohort of adult sibships. J Nephrol 29:45-51
Cheungpasitporn, Wisit; Rossetti, Sandro; Friend, Keith et al. (2016) Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol 29:211-9

Showing the most recent 10 out of 51 publications